Literature DB >> 8474826

Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn.

J P Kinsella1, S H Abman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474826

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  6 in total

1.  Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting.

Authors:  D G Markhorst; T Leenhoven; J W Uiterwijk; J Meulenbelt; A J van Vught
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 2.  The role of nitric oxide in sepsis and ARDS: synopsis of a roundtable conference held in Brussels on 18-20 March 1995.

Authors:  M P Fink; D Payen
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

3.  Bench test assessment of dosage accuracy and measurement inaccuracy in nitric oxide inhalational therapy during high frequency oscillatory ventilation.

Authors:  D G Markhorst; T Leenhoven; H R van Genderingen; J W Uiterwijk; A J van Vught
Journal:  J Clin Monit       Date:  1997-11

4.  A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst.

Authors:  P Gessler; T Nebe; A Birle; W Mueller; W Kachel
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 5.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

6.  Extracorporeal life support for neonatal respiratory failure. A 20-year experience.

Authors:  C J Shanley; R B Hirschl; R E Schumacher; M C Overbeck; T N Delosh; R A Chapman; A G Coran; R H Bartlett
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.